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Background: In Finland diabetologists have long been concerned about the level of diabetes care as the incidence
of type 1 diabetes and complicated type 2 diabetes is exceeding the capacity of specialist clinics. We compared the
outcome of diabetes care in two middle-sized Finnish municipalities with different models of diabetes care
organisation in public primary health care. In Kouvola the primary health care of all diabetic patients is based on
general practitioners, whereas in Nurmijärvi the follow-up of type 1 and most complicated type 2 diabetic patients
is assigned to a general practitioner specialised in diabetes care.
Methods: Our study population consisted of all adult diabetic patients living in the municipalities under review.
We compared the use and costs of public diabetes care, glycemic control, blood pressure, LDL-cholesterol level, the
application of the national guidelines and patient satisfaction. The main outcome measures were the costs and use
of health care services due to diabetes and its complications.
Results: In Nurmijärvi, where diabetes care was centralised, more type 1 diabetic patients were followed up in
primary health care than in Kouvola, where general practitioners need more specialist consultations. The
centralisation resulted in cost savings in the diabetes care of type 1 diabetic patients. Although the quality of care
was similar, type 1 diabetic patients were more satisfied with their follow-up in the centralised system. In the care
of type 2 diabetic patients the centralised system required fewer specialist consultations, but the quality and costs
were similar in both models.
Conclusions: The follow-up of most diabetic patients – including type 1 diabetes – can be organised in primary
health care with the same quality as in secondary care units. The centralised primary care of type 1 diabetes is less
costly and requires fewer specialist consultations.
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Patients with common diseases like arterial hyperten-
sion, bronchial asthma or type 2 diabetes (T2D) are usu-
ally followed up by general practitioners (GP) in primary
health care (PHC). However, there are some chronic dis-
eases - such as type 1 diabetes (T1D) - with challenging
treatment demands and increasing incidence. Finland
has one of the highest incidences of T1D in the world
[1]. In many municipalities, general practitioners in PHC
have to take responsibility of all diabetic patients living
in their district. The knowledge of diabetes care and the
clinical experience of general practitioners may not meet
the needs of their T1D patients and it is difficult to get
enough clinical experience if the number of T1D pa-
tients under their follow-up care is very limited. Accord-
ing to recent data, the quality standard in the care of
T1D patients remains unsatisfactory and there has not
been any improvement in glycemic control during the
past decades [2,3].
In Finland the municipalities, which pay the costs of
the public health care of their inhabitants, are interested
to produce high-quality care of common chronic dis-
eases as cost-effectively as possible [4].
The quality of diabetes care between a diabetes clinic
and a general medicine clinic has been compared [5],
but not between PHC clinics with different models of
care organisation. The reason for this may be the diffi-
culty of planning an adequate study design.
In our study, we compared the outcomes and costs of
diabetes care in two middle-sized Finnish municipalities,
which have had different models in the care of diabetic
patients in PHC for about 15 years –one is centralised,
the other based on general practitioners (Figure 1). OurFigure 1 A flow chart of the course of the study.principal interest was the balance between the quality
and costs of T1D patient care in these two municipal-
ities. We studied the use of diabetes services both in
PHC and in secondary HC, and their prices over a
period of six years (2005–2010). We measured the clin-
ical quality and coverage of diabetes care with clinical
and biometric markers and the validity of the care with
the proportion of patients followed up according to the
Finnish standards of good medical practice in diabetes
care [6]. Moreover, we asked the T1D patients how satis-
fied they were with their care.
Methods
Study subjects and the organization of primary care
The study was carried out in two medium-sized munici-
palities located in southern Finland. The follow-up of
diabetic patients in primary care had been organised in
different ways in these municipalities since the early
1990’s. In the town of Kouvola (population 31,399), the
primary diabetes care was based on general practitioners
(Figure 1). In Nurmijärvi (population 35,922), the care of
T1D patients and many of the T2D patients with en-
hanced insulin treatment had been centralised to one or
two primary care doctors with several years’ clinical ex-
perience in diabetes care. Most T2D patients were, how-
ever, followed up by their own GPs with the possibility
of consulting the diabetes-oriented GP. In the centra-
lised system of Nurmijärvi all diabetic patients with in-
creased risk of feet problems could see a foot therapist
regularly with public funding or, in acute situations,
when needed. In Kouvola there was no such facility. In
Nurmijärvi more working time of the diabetes nurses was
allocated to diabetes care (56 hours/week in Kouvola, 74
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computerised recall system for reminding patients of the
next control visit. In Nurmijärvi the diabetes team goes
through the list of insulin treated diabetic patients manu-
ally 1–2 times yearly and takes contact by phone with
those who are suspected to be dropouts and are deemed
to have a big risk of complications. Kouvola bought retinal
photographing from a private company, which has a well-
working recall system. Nurmijärvi performed retinal
screening with its own camera. The Nurmijärvi model
was less expensive but there had been problems in setting
up an automatic recall system.
In Nurmijärvi, most insulin pump therapies were initi-
ated and followed up in PHC, whereas in Kouvola the
pumps formed part of specialist-level T1D care. Insulin
pump therapy is still quite rare in Finland and most
T1D patients use multiple daily injections (MDI). In
Nurmijärvi, seven (4%) of the 170 T1D patients were on
pump therapy in the beginning of year 2005 and 33
(19%) at the end of year 2010. Insulin pump therapy is
at least twice the price of MDI in the beginning – the
eventual savings come with a delay of years or decades
as a lower risk of diabetic complications [7-9]. Still today
(November 2013) insulin pumps are a rarity in diabetes
care in Kouvola (4% of T1D patients).
The diabetic populations of the two municipalities re-
semble each other: there are no significant differences
between the mean ages of the patients in the different
diabetes groups (44.1 years in Kouvola and 44.4 years in
Nurmijärvi in T1D and 66.1 years in Kouvola and
64.4 years in Nurmijärvi in T2D at the beginning of the
study) and the number of diabetic patients in the muni-
cipalities is amazingly similar. In both municipalities,
64.1% of the population was in working age (aged 16 to
64) in 2005, but in Nurmijärvi there were somewhat
more children (about 25 vs. 15%) and fewer elderly
people (about 10 vs. 20%) [10]. There were, however, no64.5 %
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Figure 2 Proportion of type 1 diabetic patients satisfied with variousstatistically significant differences in the patients’ ages
at the time of diagnosis or in the durations of the
disease between the target populations. More detailed
information about the patient data collection and the
background data of the target populations has been
published elsewhere [11]. During the six years under
review the total costs of public PHC (per inhabitant;
including dental care) were 4–35% higher and the total
costs of public specialist care 13–21% higher in Kouvola
than in Nurmijärvi.
The target population of this analysis is shown in
Figure 1. The data on hospital care and specialist consul-
tations due to diabetes and diabetes related diseases
during the six years was collected from the National
Discharge Register (HILMO) maintained by the Finnish
National Institute for Health and Welfare. The HILMO
register includes individual-level data on inpatient care
in PHC and private health care as well as on all types of
specialist care (outpatient and inpatient) on secondary
and tertiary care levels. In regard of the outpatient care
in PHC, the period of review was one year (2005) be-
cause this data could not be analyzed automatically.
These results were multiplied by six and corrected to
the price level of 2010 in the final analysis.
Altogether 1632 (69.0%) of the recruited patients
signed an informed consent to examine their patient re-
cords, and their clinical and biometric data was collected
and used in the final analysis. However, the extent of the
use of health services by all the 2365 diabetic patients
could be calculated on the basis of register linkages.
The diabetes type (type 1 or 2) was classified based on
the data on the patients’ records in the hospital, the pri-
mary health care centre or other health care unit re-
sponsible for the follow-up. The number of diabetic
patients was very similar in the two municipalities (171
T1D patients in Kouvola and 170 in Nurmijärvi; 958
T2D patients in Kouvola and 932 in Nurmijärvi). Forty3 % 80.0 %
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dimensios of their diabetes care in two health centres.
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betes (caused by pancreatitis or resection/trauma of the
pancreas) with varying residual insulin excretion capacity
were excluded from the final analysis (Figure 1). There
were still 93 patients whose type of diabetes remained
totally unknown because of lacking data in registers and
no consent for examining their patient records. They
were similarly excluded from the final analysis. This fact
had, however, only minimal influence on the results, be-
cause these patients had not needed specialist level care
during the study years. Half of the excluded patients (66)
were from Kouvola and half (68) from Nurmijärvi.
Use of specialist consultations and hospital care
In this evaluation, only visits or treatment periods due to
diabetes or diabetes-related diseases were included in the
analysis. All episodes related to psychiatry, gynecology,
oncology etc. with no clear connection to diabetes were
excluded. Typical included diagnoses were e.g. diabetic
retinopathy, nephropathy, coronary heart disease, stroke
and diabetic foot problems. The ICD-10 diagnoses of the
PHC outpatient visits were not recorded in the HILMO
register during the period under review. Every visit was
analyzed afterwards by the study nurses and included in
the study if the main reason for the visit was the patient’s
diabetes or its complications.
Quality of follow-up
We analyzed how well the current Finnish guidelines for
the follow-up of diabetes were observed [6]. The time of
the latest foot and retinal examinations, the blood pres-
sure recording and the BMI (the body mass index) mea-
surements and the analysis of overnight albuminuria,
HbA1c and LDL-cholesterol were determined and the
results were compared between the two municipalities.
There are many reasons why the existing guidelines for
care are not always totally followed [12,13]. The reasons
may depend on the patient, the doctor or the organisation.
Patient satisfaction
50 randomly selected type 1 diabetic patients from both
municipalities were asked to answer a 13-item question-
naire, where they evaluated their satisfaction to various
parts of their diabetes care in their health care centres.
The questions concerned the laboratory services, eye ex-
aminations, foot care, nutritional therapy, professional
skills and availability of the diabetes nurses and doctors
etc. All the questions had four options to be chosen
from:
1) very satisfied
2) rather satisfied
3) rather unsatisfied
4) very unsatisfiedWe excluded the totally neutral alternative like ‘no
opinion’ in order to get stronger opinions. The patients
returned their questionnaires anonymously in envelopes
with only code numbers by which secretaries, who were
not involved in the study, could send a reminder to
those who had not answered the first posting. These sec-
retaries also opened the envelopes and calculated the re-
sults. Altogether we got 41 answers from Kouvola and
43 from Nurmijärvi. For the analysis, we combined the
questions in four categories: the skills of the personnel,
the supporting services, the easiness to contact the
personnel and the diabetes care as whole. We also com-
bined two first alternatives as ‘satisfied’ and the two lat-
est alternatives as ‘unsatisfied’ (Figure 2).
Costs of diabetes care
The costs of care on the specialist level were calculated
by means of DRG (diagnosis-related grouping) -based
prices, which are used in the invoicing of the municipal-
ities in Helsinki University Hospital (HUS) district and
in the national statistics for costs of specialised health
care services. The average DRG prices in university hos-
pitals were ten per cent higher in comparison with the
central hospital and private hospital level. The DRG
prices in local hospitals were five per cent lower in com-
parison with the price level in central hospitals. The
nearest and most frequently used hospital in Kouvola was
classified as a local hospital while in Nurmijärvi it was
classified as a central hospital with higher DRG prices. In
the most serious cases, Kouvola’s patients were treated in
the central hospital of Kotka whereas in Nurmijärvi they
were referred to Helsinki University Central Hospital.
The costs in primary health care were based on the
Finnish APR patient classification for primary care out-
patients (Ambulatory and Primary Care Related Patient
Groups), a grouping system equivalent to DRG [14]. It
has been used during the last ten years in several Finnish
municipalities covering the health services of over one
million inhabitants. The APR has been routinely used in
Kouvola Health Centre for managerial reporting of the
produced services and costs for the past four years. The
present study used the common standard unit prices of
outpatient visits and hospital care days in PHC for both
municipalities (€228.85/hospital day, €88.95/doctor visit
and €46.98/diabetes nurse visit). All costs were fixed at
the 2010 price level.
Statistics
The differences between the costs of diabetes care as well
as the mean levels of the laboratory parameters and blood
pressure were compared using the Mann–Whitney test
for two independent non-parametric samples, because the
outcomes did not distribute normally. The other compari-
sons between the patients in the two municipalities were
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satisfaction questionnaire we also used the Bonferroni
correction.
Ethics
The Ethics Committee of the Department Internal Medi-
cine in Helsinki Uusimaa Hospital District approved the
study protocol and the Helsinki-Uusimaa and Kymenlaakso
Hospital Districts granted permission to collect clinical
data from patient records and ambulance registers. More-
over, all of the patients were asked for their consent to
the use of their patient records. The HILMO register was
used with the permission of the Finnish National Institute
for Health and Welfare.
Results
Use of specialist consultations, inpatient and outpatient
care
Both T1D (133, 77.8%) and T2D (528, 55.1%) patients in
Kouvola had more outpatient hospital visits during the
years 2005 – 2010 compared with patients in Nurmijärvi
(101, 59.4%, p < 0.001 and 340, 32.9%, p < 0.01, respect-
ively). There was no marked difference in the proportion
of patients with T1D as regards the use of hospital beds
(37.4% in Kouvola and 32.9% in Nurmijärvi) or in the
average number of hospital admissions of T1D and T2D
patients.
Quality of diabetes care in PHC
A larger number of T1D patients living in Nurmijärvi
(105, 61.7%) were followed up in their health centre (p <Table 1 The coverage and the quality of the diabetes care in
Examination/
measurements
Type 1 diabetes
Examined (%) Values (Means ±
Kouvola Nurmijarvi Kouvola N
LDL cholesterol (mol/l) 71.4 84.8 2.60 ± 0.56 2
(During the latest 1.5 years) (p < 0.05) (n.s.)
BMI 51.2 77.1 24.7 ± 3.5 2
(During the latest year) (p < 0.01) p < 0.05
HbA1c (%) 89.3 94.3 8.16 ± 1.28 8
(During the latest year) (n.s.) (n.s.)
RR (mmHg) 83.3 90.4 140 ± 19/80 ± 10 140 ±
(During the latest year) (n.s.) (n.s.)
nU-alb 58.3 74.3
(During the latest 1.5 years) (p < 0.01)
Retinal photographing 73.8 53.3
(According to national
recommendations) (p < 0.05)
Examination of the feet 44.0 88.0
(During the latest 1.5 years) (p < 0.01)
Only the patients who announced themselves to be in the follow-up of the health cen0.05) than in Kouvola (84, 49.1%). As regards these pa-
tients, the Nurmijärvi patients’ follow-up included signifi-
cantly more frequently the recommended recordings of
the BMI, measurements of LDL-cholesterol and overnight
urinary albumin excretion rates and clinical feet examina-
tions than the follow-up of patients in Kouvola (Table 1).
The T2D patients were mostly followed-up in their
health centres in both municipalities (60.2% in Kouvola
and 66.0% in Nurmijärvi). LDL-cholesterol was more
often measured according to the guidelines in Nurmijärvi
than in Kouvola (p < 0.01), whereas blood pressure mea-
surements (p < 0.05) and retinal photographs (p < 0.01)
were taken more systematically in Kouvola as shown in
Table 1.
There were no statistically significant differences in the
results of the essential laboratory tests between the study
municipalities (Table 1). It is, however, worth mentioning
that in both municipalities the average HbA1c -level in
TID was lower than the national Finnish level, which
has been about 8,5% (69 mmol/mol) from decade to
decade [2,3].
In Nurmijärvi the mean HbA1c of T1D patients was
8.20% and in Kouvola 8.16%. The means of LDL choles-
terol in T1D were 2.57 mmol/l in Nurmijärvi and 2.60
in Kouvola. Respectively, the mean values for LDL in
T2D were 2.56 mmol/l in Nurmijärvi and 2.69 mmol/l
in Kouvola. The means of blood pressure values of T1D
patients measured during the first year of the study were
140/83 in Nurmijärvi and 140/80 in Kouvola (n.s.). In
T2D the results were 146/83 in Nurmijärvi and 144/80
in Kouvola (p < 0.05).the two municipalities
Type 2 diabetes
SD) Examined (%) Values (Means ± SD)
urmijarvi Kouvola Nurmijarvi Kouvola Nurmijarvi
.57 ± 0.84 70.0 78.5 2.69 ± 0.79 2.56 ± 0.74
(p < 0.01) (n.s)
6.3 ± 5.0 69.5 61.3 30.4 ± 5.4 32.5 ± 6.1
(p < 0.01) (n.s.)
.20 ± 1.28 93.2 90.7 7.09 ± 1.11 7.19 ± 1.11
(n.s.) (n.s.)
18/83 ± 10 91.2 87.0 144 ± 18/80 ± 10 146 ± 17/83 ± 10
(p < 0.05) (p < 0.05/syst., p < 0.01/diast.)
35.2 37.1
(n.s.)
49.2 35.1
(p < 0.01)
43.5 43.2
(n.s.)
tres were included in the evaluation of the proportion of examined patients.
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The T1D patients of Nurmijärvi were more satisfied with
the diabetes care in their health centre than T1D patients
living in Kouvola (Figure 2), but both patient groups were
similarly satisfied with the professional skills of the dia-
betes nurses.
Costs of diabetes care
The costs of T1D were estimated with two methods. In
the first analysis the costs of all specialist health care of
T1D patients were €1,974/pt/year in Kouvola and
€1,742/pt/year in Nurmijärvi. In the second analysis we
excluded the costs of the users of the most expensive
specialist care, including patients with diabetic nephropa-
thy and chronic dialysis treatment (over €100,000 during
the six years examined) (Figure 3). After the exclusion of
coincidental variation caused by the very expensive pa-
tients, the yearly costs per T1D patient were €1,698 in
Kouvola and €1,205 in Nurmijärvi. There was no differ-
ence in the costs of the diabetes care of T1D patients in
PHC between the two municipalities. Altogether the total
annual costs of one T1D patient were €510 lower in
Nurmijärvi than in Kouvola. The difference in annual
costs would have been €604 if the prices of specialist out-
patient and inpatient care had been calculated at the cen-
tral hospital level in both municipalities.
The costs of T2D patients were similar in both municipal-
ities (Figure 3). The total annual cost was about €1000/pt,
and there was only a slight difference of €32/pt/year for the
benefit of Nurmijärvi. With similar specialist care prices
the difference would have been €71/pt/year.
Discussion
Our study indicates that it is sensible to organise the dia-
betes primary health care of T1D patients. If the T1DFigure 3 Average yearly costs of one type 1 and type 2 diabetic patiepatients were followed up by GPs with good experience
and interest in diabetes care, fewer special care consulta-
tions would be needed and a larger proportion of patients
would get diabetes care from the local health centre. T1D
patients themselves also seem to be more satisfied with
the diabetes care provided by their local health centre.
Centralised diabetes care in PHC also resulted in cost sav-
ings. The national guidelines for the treatment of T1D
were better followed in centralised diabetes care, but the
quality of diabetes care was similar in the two differently
organised primary care models as regards glycemic con-
trol, blood pressure values and LDL-concentration. One
problem for this study was that the diagnoses for out-
patient visits in PHC were not yet entered into the elec-
tronic patient records. The quality of visits had to be
manually assessed, which caused a lot of routine work.
Our study also revealed that the more centralised care
of T2D in PHC resulted in less need for specialist con-
sultations. However, there were no consistent differences
in the quality of diabetes care in T2D patients whether
followed up by regular GPs or to some extent by GPs
with more experience in diabetes care. Moreover, the
overall costs of diabetes care of T2D patients were al-
most similar in the different diabetes care models. The
incidence of T2D is so high that every PHC doctor is
more or less experienced in its care, and the difference
in experienced and less experienced PHC doctors’ skills
has less effect on the outcome of T2D patient care.
It is very challenging to compare the effects of differ-
ently organised diabetes care models in PHC. The pro-
portion of the diabetic patients (even T1D) followed up
within occupational or private health care varies in the
municipalities. Furthermore, the use of different labora-
tory methods in the assessment of HbA1c may obscure
differences in the quality of diabetes care between thent (€ in 2010 prices).
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the HbA1c-values of the T1D patients in both municipal-
ities were lower than the Finnish values on average [2,3].
The Finnish results of T1D care measured with HbA1c
are not very good but still comparative with other coun-
tries [16]. Benchmarking is very problematic before we
have national diabetes registers in all countries and be-
fore laboratory results are truly comparative and auto-
matically available on the whole population from data
systems [17,18].
The strength of our study is that the diabetes care
under review had already been organised in the same
way for 15 years in the two municipalities before our
study began and that the data on the use of specialist
care of diabetes was collected from a period of six years
to minimise occasional changes in the use of specialist
consultations. The patient cohorts in both municipalities
were identified from the customer lists of the public
cost-free distribution points of diabetes supplies. In
Finland practically every diabetic patient uses the possi-
bility for cost-free diabetes supplies. Therefore the ori-
ginal study population represented the whole adult
diabetic populations of the municipalities. In both muni-
cipalities, a similar proportion of all diabetic patients
participated in our study, and the sizes and demograph-
ics of the final study populations were comparable.
The primary target for us was to compare the use and
costs of specialist consultations and hospital care due to
diabetes and its complications in two municipalities with
different models of PHC organisation. The diagnosis-
related database of our study includes all inpatient care
in PHC and private health care as well as outpatient and
inpatient specialist care given in local, central and uni-
versity hospitals. Kangas et al. have previously calculated
the overall costs of diabetes care in Finland [19]. Ac-
cording to his data, diabetes with its complications is by
far the most expensive disease for the Finnish health
care system. However, our study is the first follow-up
study to estimate both the use and the costs of health
services in PHC and specialist health care.
Based on our calculations, Nurmijärvi saved annually
around €86,700 with its centralised care of T1D patients
as compared to the decentralised care of T1D patients, in
which a larger proportion of patients are followed up by
specialist care units. These savings did not impair the
quality or T1D patients’ satisfaction with their care. The
cost savings calculation in Nurmijärvi was based on only
170 T1D patients. It is well known that the number of
T1D patients is steadily increasing in Finland [1]. If the
Nurmijärvi model (the centralised model) were applied
more widely in the care of T1D patients in Finland, the
annual savings would be over 4 million euros per 10,000
T1D patients. These figures indicate that it could be not
only useful but also cost-effective to assign the care ofT1D to GPs in PHC who have good interest and experi-
ence in diabetes care. The system is also applicable to the
care of some other chronic diseases.
The findings can also be expressed in another way. In
a municipality of a population of around 40,000, the
centralised primary health care of T1D and complicated
T2D patients would yield the yearly savings equal to the
annual salary of one GP.
The lower number of specialist care consultations in
Nurmijärvi can probably be attributed to consultations
between general GPs and diabetes-oriented GPs. Overall,
T1D patients in both municipalities were very satisfied
with the diabetes care provided. The PHC personnel’s
professional skills were rated higher in the centralised
system. Since there were no differences in the profes-
sional skills of the diabetic nurses, the differences in the
skills of GPs may have played a major part in patient sat-
isfaction. Especially young T1D patients may find it eas-
ier to contact the familiar personnel at the nearby
diabetes service with their minor daily problems.
However, being dependent on a little group of experi-
enced employees, the centralised T1D care system is
vulnerable. Diabetes nurses try to manage during the
diabetes-oriented doctor’s holidays - with the support of
other GPs, if needed - and a sudden absence for any rea-
son would be a major problem. The training of a new
employee inevitably takes months.
Conclusions
Our data suggests that the diabetes care of T1D patients
can be arranged in primary health care without com-
promising good quality and patient satisfaction. It can
yield cost savings through less frequent need for special-
ist consultations if a GP working at the health centre has
good experience in and motivation for diabetes care. In
regard of T2D patients, the model of providing diabetes
care in PHC had a similar effect on the quality of care
and reduced the yearly costs by 3%. These findings
should encourage primary health care units to critically
evaluate their present model of diabetes care.
Abbreviations
PHC: Primary health care; HC: Health care; T1D: Type 1 diabetes; T2D: Type 2
diabetes; BMI: Body mass index; GP: General practitioner; DRG: Diagnosis
related grouping; APR: Ambulatory and primary care related patient groups;
MDI: Multiple daily injections.
Competing interests
The authors declare that they have no financial competing interests. The first
author has a long working history in the centralised diabetes care system of
Nurmijärvi.
Authors’ contributions
This study is the main part of MH’s doctoral thesis. He has written the
manuscript. ML is a health economics researcher and has collected the data
from the HILMO register. TS is one of the two supervisors of MH’s doctoral
work and, as an endocrinologist, has frequently critically reviewed the study
and its results. AH has organised and taken part in the analysis of the data.
Honkasalo et al. BMC Health Services Research 2014, 14:26 Page 8 of 8
http://www.biomedcentral.com/1472-6963/14/26OE is the other supervisor of MH’s doctoral work and has had a major role in
the planning of the study. OE is specialised in the management and
economics of health care organisations. All authors have read and approved
the final manuscript.
Authors’ information
MH works as a GP in Nurmijärvi Health Centre and as a researcher in the
doctoral school called the Network of Academic Health Centres, University of
Helsinki (AcaHC). The objective of AcaHC is to promote scientific work and
the development of operational practices based on science as a part of the
work in primary health care and to enhance the attractiveness of primary
health care among experts who have received scientific education. The
research ideas arise from the daily work in health centres.
OE has also specialised in general practice and public health and works as
the coordinator of AcaHC.
TS has a long career as an endocrinologist and diabetologist in Helsinki
University Hospital.
ML is a Doctor of Science (Technology) and a health economics researcher
in Aalto University.
AH is a Master of Science (Economics) and works as a data analyst in Qvantel Oy.
The aim of our present study is to find a cost-effective way to organise the
care of diabetes in public health care as costs keep growing.
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